Cellectis (CLLS) Enterprise Value (2016 - 2023)
Historic Enterprise Value for Cellectis (CLLS) over the last 11 years, with Q3 2023 value amounting to -$67.4 million.
- Cellectis' Enterprise Value rose 3878.55% to -$67.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$67.4 million, marking a year-over-year increase of 3878.55%. This contributed to the annual value of -$96.5 million for FY2022, which is 98471.13% down from last year.
- According to the latest figures from Q3 2023, Cellectis' Enterprise Value is -$67.4 million, which was up 3878.55% from -$88.9 million recorded in Q2 2023.
- Cellectis' 5-year Enterprise Value high stood at $10.9 million for Q4 2021, and its period low was -$430.7 million during Q3 2019.
- Over the past 5 years, Cellectis' median Enterprise Value value was -$198.2 million (recorded in 2022), while the average stood at -$201.6 million.
- Its Enterprise Value has fluctuated over the past 5 years, first soared by 10448.62% in 2021, then plummeted by 108367.18% in 2023.
- Quarter analysis of 5 years shows Cellectis' Enterprise Value stood at -$347.8 million in 2019, then skyrocketed by 30.08% to -$243.2 million in 2020, then surged by 104.49% to $10.9 million in 2021, then tumbled by 983.99% to -$96.4 million in 2022, then skyrocketed by 30.16% to -$67.4 million in 2023.
- Its Enterprise Value was -$67.4 million in Q3 2023, compared to -$88.9 million in Q2 2023 and -$95.4 million in Q1 2023.